Temasek Holdings
China consumer brands Genki Forest, Tasogare secure funding
Two emerging Chinese beverage brands - Genki Forest and Tasogare, which focus on sparkling water and coffee, respectively - have completed new funding rounds.
China autonomous driving developer Momenta raises $500m
SAIC Motor, Toyota Motor Corporation, Robert Bosch, Yunfeng Capital, and Temasek Holdings are among the investors in a $500 million Series C funding round for Chinese autonomous driving technology developer Momenta.
Temasek leads round for China marketing content start-up
Tezign, a Chinese start-up that serves as a content-focused one-stop marketing solutions platform, has closed a second tranche of Series C funding that takes the overall total for the round to $100 million.
Deal focus: Temasek supports impact’s giant leap
Impact specialist LeapFrog Investments will use Temasek’s financial backing to broaden its reach, in terms of sectors and geographies, as well as to anchor future funds
Singapore's Azalea launches PE-backed bond offering
Temasek Holdings-owned Azalea Asset Management plans to sell S$250 million ($186 million) worth of bonds – backed by LP interests in private equity funds – to retail investors in Singapore.
Temasek agrees $500m tie-up with impact investor LeapFrog
Temasek Holdings has committed $500 million to Asia and Africa-focused impact investor LeapFrong Investments, which will see it participate as an anchor LP in the firm’s future funds.
China LiDAR specialist Innovusion raises $60m
Innovusion, a Chinese developer of LiDAR technology used in autonomous driving, has raised $60 million in funding. The company is best known as a supplier to domestic electric vehicle (EV) manufacturer Nio.
Indonesia's Sicepat secures $170m Series B
Indonesian logistics start-up Sicepat has raised a $170 million Series B round from investors including Temasek Holdings’ growth-stage PE unit Pavilion Capital.
Singapore food tech start-up raises $10m seed round
Singapore-based Next Gen, which markets a vegetarian chicken brand called Tindle, has raised $10 million in what is being called the largest-ever seed round in the food tech space.
China’s Clover Biopharmaceuticals gets $230m Series C
Chengdu-based Clover Biopharmaceuticals has raised $230 million in Series C funding led by GL Ventures and Temasek Holdings. Oceanpine Capital, OrbiMed, and Delos Capital all re-upped.
Temasek backs China industrial SaaS player
Temasek Holdings has led a RMB500 million ($77 million) round for Black Lake Technologies, a China-based software-as-a-service (SaaS) provider for manufacturers.
Temasek impact arm leads Series B for Vietnam dental player
ABC World Asia, the impact investment arm of Temasek Holdings, has led a $24 million Series B found for Kim Dental, a Vietnam-based dental clinic operator. Existing backer Aura Private Equity also participated.
Carlyle leads $123m Series D for China's Abbisko
The Carlyle Group - investing through its Asia growth fund - has led a $123 million Series D round for Chinese cancer-focused biotech developer Abbisko Therapeutics.
Temasek to anchor Info Edge's debut India VC fund
Info Edge India, a holding company for Indian jobs portal Naukri, has secured an anchor LP commitment of INR3.7 billion ($51 million) from Temasek Holdings for its debut VC fund.
Cross-border e-commerce player Wish files for US IPO
Wish, a cross-border e-commerce platform that connects Chinese merchants who primarily sell products through domestic channels like Alibaba Group’s Taobao and Tmall with consumers in the US and Europe, has filed for a US IPO.
Sequoia, Matrix back $200m Series A for China’s D3 Bio
D3 Bio, a Chinese drug developer that studies and specifically targets areas where existing approaches to care are not delivering satisfactory outcomes, has raised $200 million in Series A funding.
VC-backed Chinese online education business files for US IPO
17 Education & Technology Group, a China-based education service provider that claims to pursue an integrated “in-school plus after-school” model, has filed for a US IPO.
Ascent closes debut Myanmar fund at $88m
Ascent Capital has closed its debut Myanmar growth fund with $88 million in commitments. It is said to be the largest private equity fund dedicated to the country.
Deal focus: V2Food tackles alternative protein’s price problem
Australia’s V2Food is bringing affordability to the alternative protein space as fresh funding fuels an Asian expansion. The China entry will be a delicate proposition
China's JW Therapeutics trades up after $300m Hong Kong IPO
JW Therapeutics, a private equity-backed Chinese drug developer specializing in CAR T-cell therapies that engineer immune cells to fight cancers, has raised HK$2.33 billion ($300 million) through a Hong Kong IPO.
China's Bits x Bites hits first close on second food tech fund
Chinese food and agriculture technology investor Bits x Bites has reached a first close of $30 million on its second VC fund. The target is $70 million.
China biotech player Gracell raises $100m Series C
Wellington Management, OrbiMed and Morningside Ventures have led a $100 million Series C round for Gracell Biotechnologies, a China-based developer of cancer treatments.
China's Yuanfudao hits record valuation with $2.2b round
Yuanfudao, a Chinese education start-up that targets the K-12 segment, has raised $2.2 billion in Series G funding at a valuation of $15.5 billion, nearly double the valuation of its previous round, which closed in April.